Analysts at Oppenheimer provided their outlook on Texas Instruments Incorporated (NASDAQ:TXN) ahead of the company’s upcoming Q4 results, scheduled to be announced on Jan 24.

The analysts see an in-line set up to Q4 Street sales/EPS estimate of $4.6 billion/$2.00 but downside risk to Street's Q1 estimate of $4.4 billion/$1.87 as the cyclical correction progresses. Customer bookings are decelerating for most as cancellations pick up. Long lead time orders are most impacted. Demand weakness early last summer in personal electronics spread to broader markets including industrial beginning last quarter. The analysts characterize this as the classic “first cut” which is historically followed by roughly three more. The analysts reiterated their Outperform rating and $185 price target.